PD-1/PD-L1 Inhibitor-Associated Myocarditis: Epidemiology, Characteristics, Diagnosis, Treatment, and Potential Mechanism

Immune checkpoint inhibitors (ICIs) induce T-cell activation against cancer cells, and due to their anti-tumor function in multiple cancers, ICIs have been considered an important option for oncotherapy. PD-1/PD-L1 inhibitors are now widely used as ICIs for many types of cancers in clinical practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Hao, Qi, Yihang, Kong, Xiangyi, Wang, Zhongzhao, Fang, Yi, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062035/
https://www.ncbi.nlm.nih.gov/pubmed/35517794
http://dx.doi.org/10.3389/fphar.2022.835510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062035/
https://www.ncbi.nlm.nih.gov/pubmed/35517794
http://dx.doi.org/10.3389/fphar.2022.835510

Ejemplares similares